| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $60,963,780 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R61AI176561 | Detection Assays for Virion Susceptibility to HIV Broadly Neutralizing Antibodies in Plasma and Culture Fluids | 001 | 3 | NIH | 4/23/2025 | $523,288 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AR083363 | Lipid metabolism in the growth plate | 000 | 2 | NIH | 12/5/2024 | $482,145 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DE032692 | Novel tunable metformin-releasing injectable scaffolds to enhance dental pulp stem cell-based craniofacial bone regeneration | 000 | 2 | NIH | 3/26/2025 | $316,339 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA279108 | The pro-metastatic role of androgen receptor in estrogen receptor mutated breast cancer | 000 | 2 | NIH | 1/27/2025 | $567,729 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL171120 | High Mechanical Shear Stress-Induced Neutrophil Dysfunction in Mechanically Assisted Circulation | 000 | 2 | NIH | 12/18/2024 | $516,895 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21CA270591 | Dual inhibition of PARP and STAT3 as a novel therapeutic approach for triple-negative breast cancer | 000 | 2 | NIH | 1/14/2025 | $163,063 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA271540 | Tumor-barcoding coupled with high-throughput sequencing for quantitative radiogenomics of the abscopal response in NSCLC | 000 | 3 | NIH | 12/18/2024 | $539,293 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R37NS125632 | KPTN Loss and Megalencephaly: mTOR Activation as Therapeutic Target | 000 | 4 | NIH | 1/15/2025 | $326,002 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U01DC019370 | The gEAR portal - Advancing Data Sharing, Analysis and Discovery for Hearing and Balance Research | 000 | 5 | NIH | 3/22/2025 | $522,807 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DK130238 | Pharmacogenetics of the Response to a GLP1R Agonist | 000 | 4 | NIH | 11/25/2024 | $604,825 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA285468 | First in Class Small molecules to simultaneously inhibit protein translation and an immune checkpoint in cancers | 000 | 2 | NIH | 11/15/2024 | $575,397 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA285468 | First in Class Small molecules to simultaneously inhibit protein translation and an immune checkpoint in cancers | 001 | 2 | NIH | 11/20/2024 | $165,766 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS122777 | Targeting mitochondrial Complex I in neonatal hypoxia-ischemia | 000 | 4 | NIH | 1/15/2025 | $461,115 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH129310 | Behavioral and neural mechanisms mediating social motivation in a rat model for ASD | 000 | 3 | NIH | 11/1/2024 | $436,018 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL166402 | Targeting a Defined Surgical Stress-Induced Inflammatory Pathway to Improve Peri-Operative Outcomes | 000 | 3 | NIH | 12/20/2024 | $503,935 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DK074797 | Inter-organ signaling in heme metabolism and organismal homeostasis. | 000 | 14 | NIH | 12/31/2024 | $357,057 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL162940 | Computational Modeling of Device-Induced Platelet Activation and Receptor Shedding Relevant to Thrombosis and Bleeding in Device-Assisted Circulation | 000 | 3 | NIH | 11/27/2024 | $461,563 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HD108705 | Intersection of the mTOR/p70S6K1 signaling and the HIPPO-Yap tissue organizer in neurulation and diabetic embryopathy | 000 | 3 | NIH | 11/22/2024 | $586,642 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HD108705 | Intersection of the mTOR/p70S6K1 signaling and the HIPPO-Yap tissue organizer in neurulation and diabetic embryopathy | 001 | 3 | NIH | 4/14/2025 | $65,182 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG081436 | Defining lipid droplet homeostasis in Alzheimer's disease and aging with high molecular specificity using mass spectrometry imaging and isomer resolved lipidomics | 000 | 3 | NIH | 3/24/2025 | $496,317 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21HL172155 | Integration of Pharmacogenomics and Metabolomics in the Study of Antiplatelet Efficacy | 000 | 2 | NIH | 11/13/2024 | $116,625 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AA028070 | Synaptic Mechanisms of Nucleus Accumbens Disinhibition by Ethanol | 000 | 5 | NIH | 12/13/2024 | $449,314 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI180181 | Innate immune receptor driven programmed necrosis is coupled to hyper-synthesis of inflammatory lipid mediators in host defense | 000 | 2 | NIH | 3/25/2025 | $194,375 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI175439 | Anti-flavivirus B cell response analysis to aid vaccine design | 000 | 3 | NIH | 1/6/2025 | $748,034 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K01MH133116 | Cognitive and Neural Correlates of TMS Motor Intracortical Inhibition in Schizophrenia | 000 | 2 | NIH | 4/9/2025 | $178,203 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DA022340 | Endogenous Cannabinoid Control of Reward Substrates | 000 | 15 | NIH | 4/16/2025 | $529,576 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U01DC013817 | Cell Type Specific Transcriptional Cascades in Inner Ear Development | 000 | 10 | NIH | 11/26/2024 | $490,911 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K08AI170950 | Characterization of seasonal CoV immunity and operationalization of a novel controlled human infection model for the betacoronavirus OC43 | 000 | 3 | NIH | 4/15/2025 | $175,300 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI178839 | Subversion of Keratinocyte Function by a Tick Salivary Protein | 000 | 2 | NIH | 12/9/2024 | $194,375 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21MD018107 | Identifying Structural Vulnerability Latent Classes Associated with the Health Outcomes of Latino Immigrant Men in Baltimore | 001 | 2 | NIH | 12/2/2024 | $0 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21MD018107 | Identifying Structural Vulnerability Latent Classes Associated with the Health Outcomes of Latino Immigrant Men in Baltimore | 000 | 2 | NIH | 11/11/2024 | $186,303 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K99DA060209 | Postpartum Neurobiological Sequelae of Prescription Opioid Use During Pregnancy | 000 | 2 | NIH | 1/15/2025 | $191,608 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA269995 | Nanotherapeutic enhancement of interstitial thermal therapy for glioblastoma | 000 | 3 | NIH | 11/20/2024 | $571,318 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI161839 | Broad spectrum Shigella subunit vaccine based on conserved proteins | 000 | 5 | NIH | 1/16/2025 | $528,481 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI183982 | Deciphering hematopoietic stem cell defects in HIV exposed, uninfected infants born to ART-treated mothers | 000 | 2 | NIH | 4/18/2025 | $681,699 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG081693 | Deep-Learning Enhanced ASL MRI For Early AD Assessment | 000 | 2 | NIH | 12/16/2024 | $687,135 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R37MH080046 | Internal Dynamics of the Postsynaptic Density | 002 | 18 | NIH | 4/18/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R37MH080046 | Internal Dynamics of the Postsynaptic Density | 000 | 18 | NIH | 11/18/2024 | $789,536 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH107615 | Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment | 000 | 10 | NIH | 3/4/2025 | $566,653 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | D43TW012493 | Zambia Education Network for Implementation Science Training in Health (ZENITH) | 000 | 3 | NIH | 3/16/2025 | $245,116 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | D43TW012493 | Zambia Education Network for Implementation Science Training in Health (ZENITH) | 000 | 3 | NIH | 3/16/2025 | $50,000 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01ES033301 | Impact of Cadmium Exposure on Transporter Function and Drug Disposition in the Kidney | 000 | 4 | NIH | 3/6/2025 | $363,710 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL139613 | Targeting FAK-NEDD9 protein-protein interaction to prevent focal adhesion assembly and vascular proliferation in pulmonary arterial hypertension | 002 | 7 | NIH | 4/25/2025 | $519,022 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F31NS134126 | Sex Differences in the Bed Nucleus of the Stria Terminalis Guide Differential Pain Susceptibility | 000 | 2 | NIH | 3/6/2025 | $39,221 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DA039062 | Endocannabinoids regulate microglia in developing brain | 000 | 9 | NIH | 2/28/2025 | $422,580 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DA039062 | Endocannabinoids regulate microglia in developing brain | 001 | 9 | NIH | 4/21/2025 | $46,953 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG077541 | The inflammatory mechanisms underlying olfactory dysfunction in prognosis of TBI progression to dementia | 000 | 4 | NIH | 3/10/2025 | $552,372 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG073136 | Age-related decline in endogenous pain modulation and its impact on osteoarthritis pain | 000 | 4 | NIH | 3/7/2025 | $458,677 |
| | 2025 | 2025 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R34AR084146 | A Planning Grant for a Multi-Center Randomized Controlled Trial Comparing Resection and Endoprosthetic Reconstruction vs. Internal Fixation for Metastatic Bone Disease of the Proximal Femur | 000 | 2 | NIH | 3/13/2025 | $136,171 |
|
